Mazdutide US Phase 2 Trial: Design, Results, and Evidence Limits
What the US Phase 2 mazdutide trial found at 32 and 48 weeks, how its dual-receptor design differs, and what the evidence does not establish.
Category Longevity Research
NMN vs NR: What 2026 Head-to-Head Research Shows
Compare two 2026 human studies of NMN and NR, including blood and brain NAD+ findings, study limitations, conflicts, and unanswered questions.